🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07351071
Recruiting Not applicable

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

NCT07351071 · tracked via the Priya Life Science USA tracker
Sponsor
Medtronic - MITG
Phase
Not applicable
Started
2025-12-30
Last updated
2026-09-01

Condition(s) studied

Colorectal AnastomosisLeft-sided Colon ResectionAnastomotic LeakAnastomotic ComplicationDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesPostoperative ComplicationsAnastomotic Leaks

Investigational drug(s) / intervention(s)

Signia™ circular stapler with Tri-Staple™ Technology (Signia™ Circular Stapling system)

Signia™ circular stapler with Tri-Staple™ Technology (Signia™ Circular Stapling system): Signia™ Circular Stapling system used for the creation of an anastomosis

Study summary

The purpose of this study is to evaluate the safety and performance of the Signia™ power handle, Signia™ circular adapter, and Signia™ Tri-Staple™ 2.0 circular reloads (hereafter referred to as Signia™ circular stapler) in patients undergoing left sided colon, sigmoid, or rectal resections in a post market setting.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Preoperative Inclusion Criteria: 1. Subject is competent and willing to provide documented informed consent to participate in this clinical study 2. Subject is intended to undergo an elective left sided colon/colorectal procedure where a creation of an anastomosis will be completed with the Signia™ circular stapler 3. Subject is ≥ 18 years of age at time of consent Preoperative Exclusion Criteria: 1. Subject is unable or unwilling to comply with the study requirements or follow-up schedule 2. Subject with ASA classification ≥ IV 3. Subject is pregnant (as determined by standard site practices) 4. The procedure is an emergency procedure 5. The procedure is a revision/reoperation for the same indication 6. The subject has a documented confounding medical condition which in the opinion of the investigator, will not be appropriate for the study, or the subject has an estimated life expectancy of less than 6 months 7. Subject has participated or plans to participate in an investigational drug or device research study that would interfere with the results of this study 8. Subject will undergo multiple synchronous colon resections 9. Subject with a bleeding disorder or is undergoing anticoagulant treatment that has not been reversed (anticoagulant prophylaxis prescribed as part of the surgical protocol is allowed) 10. Subject has undergone chemotherapy or received biologics within 6 weeks prior to the day of the procedure 11. Subject has history of chronic corticosteroid use (used greater than 3 months within a year prior to the index procedure) 12. Subject has chronic immunosuppression therapy (used greater than 3 months within a year prior to the index procedure) 13. Any subject undergoing an ileal-anal pouch anastomosis surgery Intraoperative Exclusion Criteria 1. Anastomosis not attempted with the Signia™ circular stapler 2. Any subject for which the device is intended to be used outside the instructions for use (IFU)

Primary outcome measure(s)

Trial sites (10)

FacilityCityRegionStatus
Yale University New Haven Connecticut Recruiting
The University of South Florida Tampa Florida Active Not Recruiting
Wellstar Hospital Marietta Georgia Not Yet Recruiting
Massachusetts General Hospital Boston Massachusetts Not Yet Recruiting
Mayo Clinic Rochester Minnesota Not Yet Recruiting
Duke University Durham North Carolina Recruiting
The Ohio State University Wexner Medical Center Columbus Ohio Recruiting
Lankenau Institute for Medical Research Wynnewood Pennsylvania Recruiting
University of Texas Health Science Center at Houston Houston Texas Recruiting
SSM Health St. Mary's Hospital - Madison Madison Wisconsin Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07351071 on ClinicalTrials.gov ↗ ← All trials in the USA